Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan
Clinical trial NCT03439137 · COMPLETED
Trial details
- NCT number
- NCT03439137
- Sponsor
- Tanabe Pharma Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-14
- Primary completion
- 2018-12-12
- Enrollment
- 323
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.